Daniel Law

Associate at Linklaters LLP

Daniel Law

Daniel Law

Associate at Linklaters LLP

Biography

Member of the New York Bar

Experience

Daniel has broad experience representing clients on a variety of complex public and private corporate transactions, including mergers, equity and asset sales, auctions, and joint ventures. Daniel also counsels clients on corporate governance issues. Daniel has spent time in our New York and São Paulo offices.

Recent transactions where involvement can be disclosed include representing:

* Novartis on the pending sale of its vaccines business to GlaxoSmithKline plc (“GSK”) as part of a transaction where Novartis will acquire GSK's oncology business and Novartis will also combine its OTC business with GSK's consumer healthcare business in a joint venture
* Repsol on the US$6.65bn sale of its global portfolio of LNG liquefaction assets and contracts to Shell
* Citigroup on the R$2.767bn (US$1.38bn) sale of Banco Citicard S.A. and Citifinancial Promotora de Negócios e Cobrança Ltda. to Itaú Unibanco Holding S.A.
* the shareholders of Bolsa y Renta S.A. on the acquisition of the securities firm by Banco BTG Pactual S.A.
* Marfrig on its issuance of US$400m 11.25% senior notes due 2021 and concurrent tender offer and consent solicitation in respect of its 9.625% senior notes due 2016

Professional experience

August 2013 to date Associate, Linklaters, New York
January 2013 - August 2013 Secondment, Linklaters, São Paulo
2011 - 2013 Associate, Linklaters, New York

Education

2011 - Columbia Law School, J.D., Harlan Fiske Stone Scholar
2011 - University College London, LL.B., with honors

Overview
RelSci Relationships

466

Contact Data
Trying to get in touch with Daniel Law? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Daniel Law likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Group General Counsel at Novartis AG

Relationship likelihood: Strong

In-House Counsel at Novartis AG

Relationship likelihood: Strong

Senior Counsel-Legal Antitrust at Novartis AG

Relationship likelihood: Strong

Head, Corporate Legal Antitrust at Novartis AG

Relationship likelihood: Strong

In-House Counsel at Novartis AG

Relationship likelihood: Strong

Senior Legal Counsel, Mergers & Acquisitions at Novartis AG

Relationship likelihood: Strong

Vice President-Intellectual Property Transactions at Novartis AG

Relationship likelihood: Strong

Counsel at Linklaters LLP

Relationship likelihood: Strong

Partner at Freshfields Bruckhaus Deringer LLP

Relationship likelihood: Strong

Partner at Freshfields Bruckhaus Deringer LLP

Relationship likelihood: Strong

Paths to Daniel Law
Potential Connections via
Relationship Science
You
Daniel Law
Associate at Linklaters LLP
Career History
Associate
Current

Linklaters LLP is a multinational law firm headquartered in London, United Kingdom. It was founded in 1838 and is a member of the Magic Circle of leading British law firms. It currently employs around 2,600 lawyers and has 29 offices across 20 countries.

Transactions
Details Hidden

GlaxoSmithKline Plc purchases Novartis AG /Human Vaccines Operations from Novartis AG

Other Affiliations

Daniel Law is affiliated with Linklaters LLP

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Daniel Law. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Daniel Law's profile does not indicate a business or promotional relationship of any kind between RelSci and Daniel Law.